VLDLR Antibody (04) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-06596F
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 04
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for VLDLR Antibody (04) [FITC]
Immunogen
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human VLDLR (Accession#: NP_003374.3; Met 1-Ser 797).
Reactivity Notes
No cross-reactivity in ELISA with:
Human cell lysate (293 cell line)
Human cell lysate (293 cell line)
Specificity
No cross-reactivity in ELISA with: Human cell lysate (293 cell line)
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for VLDLR Antibody (04) [FITC]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: VLDLR
Long Name
Very Low Density Lipoprotein Receptor
Alternate Names
CHRMQ1, VLDL R, VLDLRCH
Gene Symbol
VLDLR
Additional VLDLR Products
Product Documents for VLDLR Antibody (04) [FITC]
Product Specific Notices for VLDLR Antibody (04) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...